Esophageal strictures: in search of the Goldilocks solution

Endoscopy 2018; 50(12): 1139-1140
DOI: 10.1055/a-0656-5650

Editorial

Referring to D. Walter et al. p. 1146–1155

Authors

Gene K. Ma

Gastroenterology Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States
Michael L. Kochman

Gastroenterology Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

References
1 Walter D, van den Berg MW, Hirdes MM. et al. Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial. Endoscopy 2018; 50: 1146-1155
2 Kochman ML, McClave SA, Boyce HW. The refractory and the recurrent esophageal stricture: a definition. Gastrointest Endosc 2005; 62: 474-475
3 Repici A, Vleggaar FP, Hassan C. et al. Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest Endosc 2010; 72: 927-934
4 Holm AN, de la Mora Levy JG, Gostout CJ. et al. Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc 2008; 67: 20-25
5 Kochman ML. Removable endoprosthetics in the management of esophageal pathology: all strictures and fistulae are not created equal. Gastrointest Endosc 2008; 67: 26-27
6 Oh YS, Kochman ML, Ahmad NA. et al. Clinical outcomes after self-expanding plastic stent placement for refractory benign esophageal strictures. Dig Dis Sci 2010; 55: 1344-1348
7 Repici A, Small AJ, Mendelson A. et al. Natural history and management of refractory benign esophageal strictures. Gastrointest Endosc 2016; 84: 222-228
8 The Goldilocks principle. Available from: https://en.wikipedia.org/wiki/Goldilocks_principle